Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free PBLS Stock Alerts

Parabilis Medicines (PBLS) Institutional Ownership

Parabilis Medicines logo
$39.36 -0.22 (-0.56%)
As of 08/21/2026 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Parabilis Medicines (NASDAQ:PBLS)

Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$695.10M
Number of
Institutional Sellers
(last 12 months)
0
Get PBLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Parabilis Medicines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PBLS Institutional Buying and Selling by Quarter

Parabilis Medicines Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/20/2026 ICONIQ Capital LLC350,000$9.58M0.3%N/A0.296%
8/20/2026 Alyeska Investment Group L.P.10,000$274K0.0%N/A0.008%
8/19/2026 Regeneron Pharmaceuticals Inc.4,166,666$114.04M64.4%N/A3.527%
8/18/2026 venBio Partners LLC5,266,697$144.15B27.8%N/A4.458%
8/18/2026 General Catalyst Group Management LLC1,600,937$43.82M23.2%N/A1.355%
8/15/2026 Jupiter Topco LLC2,296,547$62.71M0.0%N/A1.944%
8/15/2026 ARCH Venture Management LLC6,412,780$175.52B16.0%N/A5.428%
8/13/2026 ICONIQ Capital LLC350,000$9.58M0.3%N/A0.296%
8/7/2026 Alphabet Inc.4,919,498$134.65M0.1%N/A4.164%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.19,200$526K0.0%N/A0.016%
8/7/2026 Persistent Asset Partners Ltd4,130$113K0.0%N/A0.003%


PBLS Institutional Ownership - Frequently Asked Questions

During the previous two years, 10 institutional investors and hedge funds held shares of Parabilis Medicines. The most heavily invested institutionals were ARCH Venture Management LLC ($175.52B), venBio Partners LLC ($144.15B), Alphabet Inc. ($134.65M), Regeneron Pharmaceuticals Inc. ($114.04M), Jupiter Topco LLC ($62.71M), General Catalyst Group Management LLC ($43.82M), and ICONIQ Capital LLC ($9.58M).Learn more on Parabilis Medicines' institutional investors.

Of the 10 institutional investors that purchased Parabilis Medicines' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ARCH Venture Management LLC ($6.41M), venBio Partners LLC ($5.27M), Alphabet Inc. ($4.92M), Regeneron Pharmaceuticals Inc. ($4.17M), Jupiter Topco LLC ($2.30M), General Catalyst Group Management LLC ($1.60M), and ICONIQ Capital LLC ($700K).

Institutional investors have bought a total of 25,396,455 shares in the last 24 months. This purchase volume represents approximately $695.10M in transactions.


Related Companies

Institutional ownership data for NASDAQ:PBLS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/20/2026. New 13F filings are added each quarter as they're published.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel